{"id":"W4400094794","doi":"10.1016/j.jtct.2024.06.021","title":"Current Trends and Outcomes in Cellular Therapy Activity in the United States, Including Prospective Patient-Reported Outcomes Data Collection in the Center for International Blood and Marrow Transplant Research Registry","year":2024,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Institute of Environmental Health Sciences; National Institute of Allergy and Infectious Diseases; Office of Naval Research; Legend Biotech; Pharmacyclics; Takeda Oncology; Health Resources and Services Administration; MorphoSys; Seagen; Swedish Orphan Biovitrum; Omeros Corporation; Astellas Pharma; Adaptive Biotechnologies; Pfizer; Incyte; Kiadis Pharma; bluebird bio; Medac; Jazz Pharmaceuticals; BeiGene; HistoGenetics; Atara Biotherapeutics; CareDx; Actinium Pharmaceuticals; National Cancer Institute; Gilead Sciences; Sanofi; GlaxoSmithKline; CSL Behring; Bristol-Myers Squibb; AstraZeneca; Gateway for Cancer Research; Alexion Pharmaceuticals; Mallinckrodt Pharmaceuticals; Astellas Pharma US; Amgen; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation","keywords":"Medicine; Data collection; Family medicine; Statistics","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005800785,0.0003030635,0.0004107062,0.003353932,0.0004913906,0.001473079,0.0008815167,0.0004128634,0.002095182],"category_scores_gemma":[0.01107157,0.0002647503,0.0004254082,0.008394128,0.0003239151,0.0009267685,0.001004694,0.0009514327,0.0006951751],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001468127,"about_ca_system_score_gemma":0.003221683,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.03022724,"about_ca_topic_score_gemma":0.0374558,"domain_scores_codex":[0.9937907,0.001611535,0.001606112,0.0008081166,0.001788641,0.000394915],"domain_scores_gemma":[0.9742958,0.00359132,0.0115417,0.001303094,0.007144378,0.002123643],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001217704,0.000235509,0.893797,0.0003676188,0.0001065652,0.00004339515,0.0003197951,0.0004434968,0.0001910862,0.0009946811,0.05536021,0.0480189],"study_design_scores_gemma":[0.00001560104,0.0001064542,0.9762915,0.0002130534,0.00003851992,0.0001051939,0.0004608156,0.0005479489,0.0002199332,0.0002100696,0.02176655,0.00002438446],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.5457469,0.01022448,0.008171304,0.01242245,0.000578429,0.001387391,0.3805108,0.001179029,0.03977928],"genre_scores_gemma":[0.6663702,0.008534443,0.01338465,0.00345165,0.0004442748,0.002780531,0.3011116,0.0001248206,0.003797923],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03022724,"threshold_uncertainty_score":0.06010258,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1070718053539612,"score_gpt":0.3926015508572358,"score_spread":0.2855297455032746,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}